Lacrisert

   
Google
 
Web NewDrugInformation.com

Lacrisert


Drug - Lacrisert
The trade name of the product as shown on the labeling.

Dosage - INSERT; OPHTHALMIC
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Hydroxypropyl Cellulose
Multiple ingredients are in alphabetical order.

Strength - 5MG
The potency of the active ingredient(s), Hydroxypropyl Cellulose. May repeat for multiple part products.

Applicant - MERCK
The firm name holding legal responsibility for Lacrisert. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018771
The FDA assigned number to Lacrisert. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Lacrisert. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Lacrisert was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Lacrisert. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Lacrisert is in. Format is RX, OTC, DISCN.

Applicant Full Name - Merck Research Laboratories Div Merck Co Inc
The full name of the firm holding legal responsibility for the new application of Lacrisert.

Lacrisert